Monitoring lethal prostate cancer through genomic alterations in primary tumors and circulating tumor DNA
Ms. Samira Rahimirad
Affiliations:
null
null
{{ help_message }}
{{filter}}
CUA Online Library. Rahimirad S. 06/30/2024; 4136281; MP 1.5 Disclosure(s): The authors would like to thank the patients who donated samples for this study; the Marathon of Hope Canadian Cancer Network (Health Canada)/Terry Fox Research Institute, CEDARS Cancer Foundation/Royal Victoria Hospital/MUHC Cancer Center; and PROCURE Alliance for financial support. S.R was awarded several studentships, notably from Fonds de Recherche du Québec - Santé. Thanks to the McGill Genome Center Sequencing Core for sequencing services, Dr. Hussein Daoud and Dr. Magalie Celton from Illumina for technical support, and Dr. Ian Watson and his research associate-bioinformatician, Dr. Mathieu Lajoie, for helpful discussion. Bioinformatic analyses were enabled through Calcul Québec (www.calculquebec.ca) and Compute Canada (www.computecanada.ca).